Form 4: CareDx Officer Sells Shares Under 10b5-1 Plan

CareDx, Inc. reports that Secretary and General Counsel Jeffrey Adam Novack sold 2,688 shares of common stock for $20.6775 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported a transaction on May 5, 2026.
• The transaction involved the sale of 2,688 shares of common stock.
• The sale was executed at a weighted average price of $20.6775 per share, with individual sales ranging from $20.405 to $21.26.
• This transaction was conducted under a Rule 10b5-1 trading plan adopted by Mr. Novack on September 4, 2025.
• Following the transaction, Mr. Novack beneficially owns 113,924 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction executed under a pre-established trading plan, which is a common and accepted practice.

Negatives

• Company insider sold a portion of their holdings.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan indicates a pre-planned sale, often used by executives to diversify holdings or manage personal finances without the appearance of trading on material non-public information.

Stakeholder Impact

• Shareholders: The sale by an insider may be perceived neutrally given it was executed under a 10b5-1 plan, suggesting it was pre-determined and not based on recent material information. The remaining beneficial ownership by the insider is substantial.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, 10b5-1 Plan, CareDx, CDNA, Stock Sale, Beneficial Ownership